Is soy consumption good or bad for the breast?

Area of Science:

• Nutritional Science
• Oncology
• Molecular Biology

Background:

• Genistein, a soy isoflavone, activates estrogen receptors (ERs) and mimics estradiol.
• Estrogens are linked to increased breast cancer risk, raising questions about soy's safety.
• Genistein promotes the growth of ER-positive human breast cancer cells.

Purpose of the Study:

• To review the literature on the safety of soy and genistein concerning breast cancer risk and recurrence.
• To explore the potential protective effects of early-life soy intake on breast cancer.
• To examine the impact of soy consumption on breast cancer survivors' prognosis.

Main Methods:

• Literature review of existing studies on soy consumption, genistein, and breast cancer.
• Analysis of human studies investigating genistein's effect on breast cancer recurrence in Western women.
• Examination of data on Asian breast cancer survivors' outcomes with continued soy diet.

Main Results:

• Moderate lifetime soy consumption is associated with lower breast cancer risk, potentially due to early-life intake.
• Moderate soy intake does not increase breast cancer recurrence risk in Western women.
• Asian breast cancer survivors consuming soy show a better prognosis.

Conclusions:

• Early-life soy intake may reduce breast cancer risk and recurrence.
• Mechanisms may involve epigenetic changes altering gene expression related to mammary cell fate.
• Further research is needed to elucidate the specific mechanisms behind soy's protective effects.